Why TransMedics Group, Inc.’s (TMDX) Stock Is Up 6.45%
As of Monday, November 09, TransMedics Group, Inc.’s TMDX share price has surged by 6.45%, which has investors questioning if this is right time to sell.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Jenna Brashear
Rosalio Madrigal
Rosalio Madrigal
Rosalio Madrigal
| Share Statistics | TMDX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3,202.8 | $380.3 | 61% |
|
| Shares Out (Mil) | 40.8 | 41.2 | 43% |
|
| Institutional Ownership | 97.1% | 84.0% | 72% |
|
| Float (Mil) | 33.6 | 35.2 | 38% |
|
| Beta | 2.10 | 0.85 | 93% |
|
| Avg Daily Volume (000s) | 1,589 | 341 | 76% |
|
| Price Change (52-week) |
(20.2%) | 59.6% | 35% |
|
| Growth | TMDX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 88.3% | 11.8% | 98% |
|
| Net Income (5yr) | 53.9% | (5.6%) | 95% |
|
| EPS (5yr) | 44.0% | 10.6% | 91 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 90.0% | (16.0%) | 98% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 9 | 10 | 10 | |
| Current EPS | $0.451 | $1.670 | $2.486 | |
| Month Ago EPS | $0.499 | $1.513 | $2.254 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 2 | 1 | 1 | |
| Three Months Ago EPS | $0.530 | $1.559 | $2.306 | |
| Year/Year Chg | (2.6%) | (65.7%) | (29.4%) | |
| Financials | TMDX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $728 | $127 | 45% |
|
| Net Income (TTM) (Mil) | $145 | ($9) | 64% |
|
| EPS (TTM) | $4.191 | ($0.300) | 83% |
|
| Operating Cash Flow (TTM) (Mil) | $112 | ($1) | 52% |
|
| Net Cash Flow (TTM) (Mil) | $45 | $2 | 69% |
|
| Long-Term Debt (Q1) (Mil) | $808 | $25 | 63% |
|
| Enterprise Value (Q1) (Mil) | $3,533 | $400 | 57% |
|
| Valuation | TMDX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 5.81 | 2.62 | 84% |
|
| P/E | 23.8 | 26.0 | 62% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.5 | 1.3 | 28% |
|
| Ratios | TMDX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 58.6% | 59.1% | 71% |
|
| Net Margin | 19.9% | (4.5%) | 78% |
|
| ROA | 11.7% | (11.0%) | 89% |
|
| ROE | 31.9% | (8.5%) | 88% |
|
| Liabilities to Assets | 63.7% | 45.9% | 59% |
|
| F-Score | 3 | 4 | 18% |
|
TransMedics Group, Inc. did not pass any screens on 11/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors